166 related articles for article (PubMed ID: 21217111)
1. Chromosome fragility in patients with Fanconi anaemia: diagnostic implications and clinical impact.
Castella M; Pujol R; Callén E; Ramírez MJ; Casado JA; Talavera M; Ferro T; Muñoz A; Sevilla J; Madero L; Cela E; Beléndez C; de Heredia CD; Olivé T; de Toledo JS; Badell I; Estella J; Dasí Á; Rodríguez-Villa A; Gómez P; Tapia M; Molinés A; Figuera Á; Bueren JA; Surrallés J
J Med Genet; 2011 Apr; 48(4):242-50. PubMed ID: 21217111
[TBL] [Abstract][Full Text] [Related]
2. The clastogenic response of the 1q12 heterochromatic region to DNA cross-linking agents is independent of the Fanconi anaemia pathway.
Callén E; Ramírez MJ; Creus A; Marcos R; Frias S; Molina B; Badell I; Olivé T; Ortega JJ; Surrallés J
Carcinogenesis; 2002 Aug; 23(8):1267-71. PubMed ID: 12151343
[TBL] [Abstract][Full Text] [Related]
3. Positive diepoxybutane test in only one of two brothers found to be compound heterozygotes for Fanconi's anaemia complementation group C mutations.
Dokal I; Chase A; Morgan NV; Coulthard S; Hall G; Mathew CG; Roberts I
Br J Haematol; 1996 Jun; 93(4):813-6. PubMed ID: 8703809
[TBL] [Abstract][Full Text] [Related]
4. Clinical, genetic and cytogenetic study of Fanconi anemia in an Indian population.
Korgaonkar S; Ghosh K; Vundinti BR
Hematology; 2010 Feb; 15(1):58-62. PubMed ID: 20132664
[TBL] [Abstract][Full Text] [Related]
5. A novel diagnostic screen for defects in the Fanconi anemia pathway.
Shimamura A; Montes de Oca R; Svenson JL; Haining N; Moreau LA; Nathan DG; D'Andrea AD
Blood; 2002 Dec; 100(13):4649-54. PubMed ID: 12393398
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of Fanconi anemia and aplastic anemia using mitomycin C test in Tunisia.
Talmoudi F; Kilani O; Ayed W; Ben Halim N; Mellouli F; Torjmane L; Aissaoui L; Ben Youssef Y; Kammoun L; Ben Othmane T; Bejaoui M; Ben Romdhane N; Elloumi M; Hadiji S; Hentati S; Chemkhi I; Abidli N; Guermani H; Abdelhak S; Amouri A
C R Biol; 2013 Jan; 336(1):29-33. PubMed ID: 23537767
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of immortalized fibroblastoid cell lines from an FA(C) mouse model.
Tomkins DJ; Care M; Carreau M; Buchwald M
Mutat Res; 1998 Jul; 408(1):27-35. PubMed ID: 9678061
[TBL] [Abstract][Full Text] [Related]
8. Relationship between chromosome fragility, aneuploidy and severity of the haematological disease in Fanconi anaemia.
Callén E; Ramírez MJ; Creus A; Marcos R; Ortega JJ; Olivé T; Badell I; Surrallés J
Mutat Res; 2002 Jul; 504(1-2):75-83. PubMed ID: 12106648
[TBL] [Abstract][Full Text] [Related]
9. The genetics of Fanconi's anaemia.
Dokal I
Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):407-25. PubMed ID: 11030042
[TBL] [Abstract][Full Text] [Related]
10. [Fanconi anemia: cytogenetic diagnosis of 40 cases].
Porto B; Sousa R; Ponte F; Torgal A; Campilho F; Campos A; Gonçalves C; Barbot J
Acta Med Port; 2011; 24(3):405-12. PubMed ID: 22015027
[TBL] [Abstract][Full Text] [Related]
11. The sensitivity of Fanconi anaemia group C cells to apoptosis induced by mitomycin C is due to oxygen radical generation, not DNA crosslinking.
Clarke AA; Philpott NJ; Gordon-Smith EC; Rutherford TR
Br J Haematol; 1997 Feb; 96(2):240-7. PubMed ID: 9029006
[TBL] [Abstract][Full Text] [Related]
12. Comparison of chromosome breakage in non-mosaic and mosaic patients with Fanconi anemia, relatives, and patients with other inherited bone marrow failure syndromes.
Fargo JH; Rochowski A; Giri N; Savage SA; Olson SB; Alter BP
Cytogenet Genome Res; 2014; 144(1):15-27. PubMed ID: 25227706
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of Fanconi Anaemia by ionising radiation- or mitomycin C-induced micronuclei.
Francies FZ; Wainwright R; Poole J; De Leeneer K; Coene I; Wieme G; Poirel HA; Brichard B; Vermeulen S; Vral A; Slabbert J; Claes K; Baeyens A
DNA Repair (Amst); 2018 Jan; 61():17-24. PubMed ID: 29154021
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic differentiation of Fanconi anemia, "idiopathic" aplastic anemia, and Fanconi anemia heterozygotes.
Cervenka J; Hirsch BA
Am J Med Genet; 1983 Jun; 15(2):211-23. PubMed ID: 6410915
[TBL] [Abstract][Full Text] [Related]
15. Microcell mediated chromosome transfer maps the Fanconi anaemia group D gene to chromosome 3p.
Whitney M; Thayer M; Reifsteck C; Olson S; Smith L; Jakobs PM; Leach R; Naylor S; Joenje H; Grompe M
Nat Genet; 1995 Nov; 11(3):341-3. PubMed ID: 7581463
[TBL] [Abstract][Full Text] [Related]
16. Mitomycin C and diepoxybutane action mechanisms and FANCC protein functions: further insights into the role for oxidative stress in Fanconi's anaemia phenotype.
Pagano G
Carcinogenesis; 2000 May; 21(5):1067-8. PubMed ID: 10783335
[TBL] [Abstract][Full Text] [Related]
17. Fanconi anemia screening by diepoxybutane and mitomicin C tests in Korean children with bone marrow failure syndromes.
Kook H; Cho D; Cho SH; Hong WP; Kim CJ; Park JY; Yoon WS; Ryang DW; Hwang TJ
J Korean Med Sci; 1998 Dec; 13(6):623-8. PubMed ID: 9886171
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of Fanconi anemia by diepoxybutane analysis.
Auerbach AD
Curr Protoc Hum Genet; 2015 Apr; 85():8.7.1-8.7.17. PubMed ID: 25827349
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of diepoxybutane sensitivity and cell cycle blockage in the diagnosis of Fanconi anemia.
Seyschab H; Friedl R; Sun Y; Schindler D; Hoehn H; Hentze S; Schroeder-Kurth T
Blood; 1995 Apr; 85(8):2233-7. PubMed ID: 7718895
[TBL] [Abstract][Full Text] [Related]
20. In vitro effect of fludarabine, cyclophosphamide, and cytosine arabinoside on chromosome breakage in Fanconi anemia patients: relevance to stem cell transplantation.
Yabe M; Yabe H; Hamanoue S; Inoue H; Matsumoto M; Koike T; Ishiguro H; Morimoto T; Arakawa S; Ohshima T; Masukawa A; Miyachi H; Yamashita T; Katob S
Int J Hematol; 2007 May; 85(4):354-61. PubMed ID: 17483082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
